The Securities and Exchange Commission (SEC) awarded more than $17 million to a whistleblower represented by Whistleblower Law Collaborative’s Suzanne Durrell and Bob Thomas. The whistleblower client submitted a tip under the SEC Whistleblower Program. The tip and subsequent information and assistance led to monetary sanctions in an SEC enforcement action and a related action. The SEC awarded our client 30% of the monetary sanctions collected, the highest percentage award allowed under the SEC Whistleblower Program.
[This] award underscores the SEC’s commitment to rewarding meritorious whistleblowers who provide valuable information and exemplary cooperation that advance the agency’s enforcement efforts,
–Creola Kelly, Chief of the SEC’s Office of the Whistleblower in announcing the award.
Attorneys Bob Thomas and Suzanne Durrell emphasized: “We and our client are very gratified that the SEC recognized and rewarded the extraordinary contributions of our client. We applaud the SEC for its impressive skill and dedication in prosecuting this matter, and for its highly successful track record in working with whistleblowers and their attorneys.”
In general, a whistleblower files a “Tip, Complaint, or Referral” form (TCR) with the SEC office of the whistleblower. The SEC then investigates and at its choice may pursue claims based on the tip. SEC periodically posts “notices of covered action.” These notices detail any results potentially subject to whistleblower rewards. Then, whistleblowers must file to claim their share of the recovery. Notably, the program does not give the whistleblower the right to pursue their own claims if the SEC does not.
The SEC may award between 10-30% of the monetary recoveries to an eligible whistleblower. It uses several factors in deciding how much to award. Here, the SEC noted that the highest possible award was appropriate because:
The SEC Whistleblower Program has been very successful. Since the program began, enforcement matters brought using information from meritorious whistleblowers have resulted in orders for nearly $5 billion in total monetary sanctions. This money is returned to the Investor Protection Fund for the benefit of taxpayers, defrauded investors, and others harmed by marketplace misconduct.
Since 2012, the SEC has awarded approximately $1.3 billion to over 275 individual whistleblowers. Importantly, the SEC provides all awards from the Investor Protection Fund. As a result, no money is taken or withheld from harmed investors to pay whistleblower awards.
Whistleblowers may be eligible for an award when they voluntarily provide the SEC with original, timely, and credible information that leads to a successful enforcement action. Whistleblower awards can range from 10 percent to 30 percent of the money collected when the monetary sanctions exceed $1 million.
Further, as in this matter, the SEC protects the confidentiality of whistleblowers and does not disclose any information that could reveal a whistleblower’s identity.
The Whistleblower Law Collaborative has secured awards for clients in several SEC whistleblower cases. It also represents whistleblowers in ongoing SEC investigations.
Whistleblower Law Collaborative LLC, based in Boston, devotes its practice entirely to representing clients nationwide in bringing actions under the federal and state whistleblower laws and programs, False Claims Acts and other whistleblower programs. We have extensive experience representing whistleblowers in False Claims Act and SEC matters.
If you are considering submitting a tip, complaint, or referral to the SEC or are aware of other types of fraud, contact us for a free, confidential consultation.
The United States has resolved allegations against two clinical laboratories and their owners involving genetic testing fraud. Metric Lab Services, a clinical lab in Mississippi, Spectrum Diagnostic Labs, a clinical lab in Texas, and two of their owners agreed to pay $5.7 million. The government alleged that they billed Medicare millions of dollars for unnecessary genetic cancer tests. A client of Whistleblower Law Collaborative LLC alerted authorities to the fraudulent scheme.
The government alleged that the labs falsely billed Medicare for unnecessary genetic cancer tests. Metric Labs and Spectrum Labs paid kickbacks to telemarketers to recruit unsuspecting Medicare beneficiaries to sign up for unnecessary testing.
Additionally, the telemarketers paid doctors to order the tests. In many instances, the doctor who requested the genetic cancer testing had never spoken to the patient. The doctors ordered the costly testing because they received a kickback payment for every test they requested.
Our client came forward to alert the government to the significant genetic testing fraud activities. As a result, the government launched a multi-state investigation. That investigation was led by the U.S. Attorney’s Office for the District of New Jersey, the U.S. Department of Justice Civil Division, and the Office of Inspector General of the U.S. Department of Health and Human Services.
On July 21, 2022, the United States Attorney for the District of New Jersey and the U.S. Department of Justice announced that they had resolved the allegations that the two labs paid kickbacks to generate millions of dollars in genetic cancer tests.
In announcing the settlement, Philip R Selinger, the U.S. Attorney for New Jersey, said:
Rather than compete fairly for business, these labs engaged in a brazen kickback scheme to rake in millions of dollars from the Medicare program.
Brian M. Boyton, the Principal Deputy Assistant Attorney General for the Civil Division at the Department of Justice, added: “The department will continue to pursue those who undermine the integrity of federal health care programs and waste taxpayer dollars.”
Whistleblower Law Collaborative LLC attorneys Bob Thomas and Bruce Judge commended the outstanding efforts of the government. Mr. Judge cited the skillful work done by Assistant U.S. Attorney Andrew A. Caffrey, III and former Assistant U.S. Attorney Bernard J. Cooney, both of the District of New Jersey, along with Department of Justice Trial Attorney J. Jennifer Koh. Mr. Judge remarked “over the past several years, there has been a flood of genetic testing fraud schemes across the country. This settlement is an impressive example of the government holding dishonest laboratories and their individual owners accountable.”
If you have information concerning genetic testing fraud or other types of healthcare fraud, we urge you to contact the Whistleblower Law Collaborative to for a free and confidential consultation.